| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/17/2011 | US20110039846 Iminopyridine derivatives and use thereof |
| 02/17/2011 | US20110039845 2-aminoquinazoline derivative |
| 02/17/2011 | US20110039843 Harmful arthropod control composition, and fused heterocyclic compound |
| 02/17/2011 | US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 02/17/2011 | US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039827 Substituted hydroxamic acids and uses thereof |
| 02/17/2011 | US20110039821 Fused Phenyl Amido Heterocyclic Compounds |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039718 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
| 02/17/2011 | US20110039693 Pyrimidylmethyl Sulfonamide Compounds |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110037060 Organic light emitting device |
| 02/17/2011 | US20110037027 Fluorine derivatives for organic electroluminescence devices |
| 02/17/2011 | CA2770724A1 Compounds and methods of use thereof |
| 02/17/2011 | CA2768749A1 Inhibitors of jnk |
| 02/17/2011 | CA2768636A1 Microbiocidal heterocycles |
| 02/17/2011 | CA2767965A1 Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
| 02/16/2011 | EP2284168A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/16/2011 | EP2284167A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/16/2011 | EP2284166A1 Arylsulfonamides with analgetic activity |
| 02/16/2011 | EP2284159A1 5-hydroxypyrimidine-4-carboxamide compound |
| 02/16/2011 | EP2284157A1 Quinolines useful in treating cardiovascular disease |
| 02/16/2011 | EP2283015A2 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators |
| 02/16/2011 | EP2283009A1 Inhibitors of jnk |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283006A1 Pyrrole antifungal agents |
| 02/16/2011 | EP2283005A2 Cisatracurium derivatives, preparation and uses thereof |
| 02/16/2011 | EP2283000A2 3- or 4-substituted piperidine compounds |
| 02/16/2011 | EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 02/16/2011 | EP2282996A1 Tetrahydroisoquinolines as antimalarial agents |
| 02/16/2011 | EP2111401B1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer |
| 02/16/2011 | EP2046762B1 Triazolyl phenyl benzenesulfonamides |
| 02/16/2011 | EP2010518B1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
| 02/16/2011 | EP1773808B1 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/16/2011 | EP1771422B1 Quinazolinone derivatives as parp inhibitors |
| 02/16/2011 | EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor |
| 02/16/2011 | CN1989113B Quinazoline derivatives |
| 02/16/2011 | CN1972926B Indole derivatives as histamine receptor antagonists |
| 02/16/2011 | CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands |
| 02/16/2011 | CN101977907A Pyrrolidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977906A 4-pyridinone compounds and their use for cancer |
| 02/16/2011 | CN101977905A 4-pyridinone compounds and their use for cancer |
| 02/16/2011 | CN101977904A Aminopiperidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977900A 5-fluoro pyrimidine derivatives |
| 02/16/2011 | CN101977655A Indazole derivatives |
| 02/16/2011 | CN101977504A Fungicide hydroximoyl-tetrazole derivatives |
| 02/16/2011 | CN101977503A Fungicide hydroximoyl-tetrazole derivatives |
| 02/16/2011 | CN101977502A Fungicide hydroximoyl-tetrazole derivatives |
| 02/16/2011 | CN101973982A Production method of fasudil hydrochloride |
| 02/16/2011 | CN101973981A Refining method of 1-(5-isoquinoline sulfonyl) homopiperazine hydrochloride |
| 02/16/2011 | CN101973946A Phenazine-1-carboxylic acids derivative and preparation method thereof |
| 02/16/2011 | CN101973934A 1,5-disubstituted aryl-1,4-pentadiene-3-ketoxime ether compound and preparation method thereof and insecticidal activity application |
| 02/16/2011 | CN101538245B One-class pyridazinone compounds and preparation method and application thereof |
| 02/16/2011 | CN101432268B Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor |
| 02/16/2011 | CN101238106B Fluoro substituted 2-oxo azepan derivatives |
| 02/16/2011 | CN101023064B Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 02/16/2011 | CN101012203B 1,2,4-triazol derivatives, method for preparing the same |
| 02/15/2011 | USRE42152 FDA Orange book listed patent for plerixafor |
| 02/15/2011 | US7888512 Synthesis of nicotine derivatives from nicotine |
| 02/15/2011 | US7888511 Optically pure; resolution; dissolving (S)-(-)-binol, a weak base and the racemic form of omeprazole and crystallization; then removing the binol moiety from the formed inclusion complex by filtration or extraction; binol only used in 0.5 to 0.7 mole equivalent which is less than other procedures |
| 02/15/2011 | US7888510 1,4-disubstituted piperidine compounds like N-(9-Ethyl-9H-carbazol-3-yl)-2-[4-(2-hydroxymethyl-6-methyl-phenylamino)-piperidine-yl]acetamide; chloroacetyl chloride is reacted with respective compounds in the presence of dichloromethane and triethylamine or diisopropylethylamine |
| 02/15/2011 | US7888509 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 02/15/2011 | US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/15/2011 | US7888384 Heterocyclic derivatives for modulation of calcium channels |
| 02/15/2011 | US7888366 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/15/2011 | US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 02/15/2011 | US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/15/2011 | US7888287 6-Amino-5-chloro-2-(4-chloro-2,6-difluoro-3-methoxy-phenyl)pyrimidine-4-carboxylic Acid Methyl Ester; preemergence herbicides; applying to the soil in rice fields; broad spectrum of weed control against woody plants, grasses and sedges as well as broadleafs |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887784 Potent and selective binding affinity for the norpeinephrine transporter (NET) protein found in peripheral and central nervous system tissues |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2592986C Heteroaromatic quinoline compounds |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/10/2011 | WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016504A1 Nitrogenous-ring acylguanidine derivative |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016234A1 Picolinamide derivatives as ttx-s blockers |
| 02/10/2011 | WO2011015728A1 Novel dihydroindolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/10/2011 | WO2011015658A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015657A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015629A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors |
| 02/10/2011 | WO2011015524A2 Fungicide heterocycles derivatives |
| 02/10/2011 | US20110034696 Process for producing anthranilamide compound |
| 02/10/2011 | US20110034695 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 02/10/2011 | US20110034691 Process for the Production of Fused, Tricyclic Sulfonamides |
| 02/10/2011 | US20110034690 Process for the preparation of pure prulifloxacin |
| 02/10/2011 | US20110034517 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/10/2011 | US20110034515 Indole modulators of the alpha 7 nicotinic acetylcholine receptor |
| 02/10/2011 | US20110034514 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |